Evidence map›Paper›PMID 39934299›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2025

Theranostics using

Tadashi Watabe, Takumi Iwasawa, Hiroyuki Kimura, Yoshifumi Shirakami, Sadahiro Naka, Kazuko Kaneda, Takanori Kobayashi, Marina Omokawa, Yusuke Yagi, Noriyuki Tomiyama and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. [Npj imaging · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Tadashi WatabeDepartment of Radiology, Graduate School of Medicine, Osaka University, Suita, Japan. watabe.tadashi.med@osaka-u.ac.jp.ORCID 0000-0001-8658-2395
Takumi IwasawaInstitute of Life Innovation Studies, Toyo University, Tokyo, Japan.
Hiroyuki KimuraResearch Center for Experimental Modeling of Human Disease, Kanazawa University, Kanazawa, Japan.
Yoshifumi ShirakamiInstitute for Radiation Sciences, Osaka University, Suita, Japan.
Sadahiro NakaDepartment of Pharmacy, Osaka University Hospital, Suita, Japan.
Kazuko KanedaInstitute for Radiation Sciences, Osaka University, Suita, Japan.
Takanori KobayashiDepartment of Radiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Marina OmokawaFaculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Yusuke YagiDepartment of Radiological Technology, Faculty of Medicinal Science, Kyoto College of Medical Science, Nantan, Japan.
Noriyuki TomiyamaDepartment of Radiology, Graduate School of Medicine, Osaka University, Suita, Japan.
Kazunori KatoInstitute of Life Innovation Studies, Toyo University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeErythropoietin-producing hepatocellular A2 (EphA2) is abundantly expressed in various types of cancers. This study aimed to assess the therapeutic effect of

methodsAn EphA2 monoclonal antibody (mAb) (clone 230-1) was labeled with

resultsOn [

conclusion[

Indexed as

Antibodies, MonoclonalLutetiumRadioisotopesReceptor, EphA2Theranostic NanomedicineZirconiumAnimalsCell Line, TumorHumansMicePositron-Emission TomographyRadiopharmaceuticalsTissue DistributionAntibodies, MonoclonalEPHA2 protein, humanLutetiumLutetium-177RadioisotopesRadiopharmaceuticalsReceptor, EphA2ZirconiumZirconium-89AntibodyEphA2Lutetium (177Lu)TheranosticsZirconium (89Zr)

Identifiers

PMID39934299
PMCPMC12162727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.